McKesson Corporation | Large-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 90.8B
Gross Profit 3.6B 4.01%
Operating Income 1.7B 1.83%
Net Income 1.3B 1.44%

Balance Sheet Metrics

Total Assets 75.1B
Total Liabilities 76.8B
Shareholders Equity -1.7B

Cash Flow Metrics

Operating Cash Flow 2.2B
Free Cash Flow 7.5B

Revenue & Profitability Trend

McKesson Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i359.1B309.0B276.7B264.0B238.2B
Cost of Goods Sold i345.7B296.1B264.4B250.8B226.1B
Gross Profit i13.3B12.8B12.4B13.1B12.1B
Gross Margin % i3.7%4.2%4.5%5.0%5.1%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i8.5B8.7B7.8B10.5B8.8B
Other Operating Expenses i-----
Total Operating Expenses i8.5B8.7B7.8B10.5B8.8B
Operating Income i4.8B4.2B4.6B2.6B3.3B
Operating Margin % i1.3%1.4%1.7%1.0%1.4%
Non-Operating Items
Interest Income i173.0M118.0M107.0M10.0M12.0M
Interest Expense i265.0M252.0M248.0M178.0M217.0M
Other Non-Operating Income-365.0M-248.0M189.0M-497.0M-8.1B
Pre-tax Income i4.4B3.8B4.6B1.9B-5.0B
Income Tax i878.0M629.0M905.0M636.0M-695.0M
Effective Tax Rate % i20.1%16.6%19.5%33.0%0.0%
Net Income i3.5B3.2B3.7B1.3B-4.3B
Net Margin % i1.0%1.0%1.3%0.5%-1.8%
Key Metrics
EBITDA i5.6B5.0B5.6B3.5B4.2B
EPS (Basic) i$25.86$22.54$25.23$7.32$-28.26
EPS (Diluted) i$25.72$22.39$25.03$7.23$-28.26
Basic Shares Outstanding i127400000133200000141100000152300000160600000
Diluted Shares Outstanding i127400000133200000141100000152300000160600000

Income Statement Trend

McKesson Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i5.7B4.6B4.7B3.5B6.3B
Short-term Investments i-----
Accounts Receivable i22.3B19.4B17.2B16.4B17.1B
Inventory i23.0B21.1B19.7B18.7B19.2B
Other Current Assets1.1B626.0M513.0M898.0M665.0M
Total Current Assets i55.4B48.0B44.3B46.2B45.4B
Non-Current Assets
Property, Plant & Equipment i1.8B1.7B1.6B1.5B2.1B
Goodwill i21.5B22.4B22.2B21.0B21.9B
Intangible Assets i1.5B2.1B2.3B2.1B2.9B
Long-term Investments-----
Other Non-Current Assets4.0B3.2B2.0B1.9B2.6B
Total Non-Current Assets i19.7B19.5B18.0B17.1B19.6B
Total Assets i75.1B67.4B62.3B63.3B65.0B
Liabilities
Current Liabilities
Accounts Payable i55.3B47.1B42.5B38.1B39.0B
Short-term Debt i1.4B345.0M1.3B1.1B1.1B
Current Portion of Long-term Debt-----
Other Current Liabilities--5.0M4.7B9.0M
Total Current Liabilities i61.6B52.4B48.0B48.5B44.1B
Non-Current Liabilities
Long-term Debt i5.9B7.0B6.0B6.4B8.3B
Deferred Tax Liabilities i1.0B917.0M1.4B1.4B1.4B
Other Non-Current Liabilities8.3B8.7B8.4B8.8B9.8B
Total Non-Current Liabilities i15.2B16.7B15.9B16.6B19.5B
Total Liabilities i76.8B69.0B63.8B65.1B63.6B
Equity
Common Stock i3.0M3.0M3.0M2.0M2.0M
Retained Earnings i17.9B15.0B12.3B9.0B8.2B
Treasury Stock i27.4B24.1B21.0B17.0B13.7B
Other Equity-----
Total Shareholders Equity i-1.7B-1.6B-1.5B-1.8B1.4B
Key Metrics
Total Debt i7.4B7.4B7.3B7.5B9.4B
Working Capital i-6.2B-4.4B-3.7B-2.2B1.3B

Balance Sheet Composition

McKesson Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i3.5B3.2B3.7B1.3B-4.3B
Depreciation & Amortization i636.0M635.0M608.0M760.0M887.0M
Stock-Based Compensation i-----
Working Capital Changes i-7.1B-4.7B-3.4B-2.9B6.4B
Operating Cash Flow i-2.7B-1.1B1.5B51.0M3.0B
Investing Activities
Capital Expenditures i-537.0M-431.0M-390.0M-388.0M-451.0M
Acquisitions i155.0M-225.0M210.0M572.0M365.0M
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-411.0M-816.0M-374.0M58.0M-225.0M
Financing Activities
Share Repurchases i-3.1B-3.0B-3.6B-3.5B-742.0M
Dividends Paid i-345.0M-314.0M-292.0M-277.0M-276.0M
Debt Issuance i498.0M991.0M997.0M498.0M500.0M
Debt Repayment i-15.6B-20.9B-9.7B-12.8B-7.4B
Financing Cash Flow i-19.1B-23.3B-12.8B-17.5B-8.0B
Free Cash Flow i5.2B3.6B4.6B3.9B3.9B
Net Change in Cash i-22.1B-25.2B-11.7B-17.4B-5.2B

Cash Flow Trend

McKesson Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 27.10
Forward P/E 18.39
Price to Book -100.73
Price to Sales 0.22
PEG Ratio -2.51

Profitability Ratios

Profit Margin 0.84%
Operating Margin 1.29%
Return on Equity -194.51%
Return on Assets 4.18%

Financial Health

Current Ratio 0.88
Debt to Equity -11.52
Beta 0.50

Per Share Data

EPS (TTM) $24.98
Book Value per Share $-15.74
Revenue per Share $2,992.63

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
mck84.2B27.10-100.73-194.51%0.84%-11.52
Cencora 56.7B33.8055.93141.78%0.55%827.73
Cardinal Health 35.7B23.20-13.52-59.26%0.70%-3.56
Henry Schein 8.2B21.792.408.12%3.05%68.55
Patterson Companies 2.8B20.482.8014.11%2.13%88.87
Owens & Minor 408.6M-1.11-1.44-148.42%-11.18%-7.48

Financial data is updated regularly. All figures are in the company's reporting currency.